Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The primary objective of this article is to provide an overview of Artificial Pancreas projects by stage in human trials. Our analysis evaluated the companies involved in AP human trials, differentiating device characteristics, most advanced stage of testing, and the number of trials in which each device was involved.
The Artificial Pancreas is an important and substantial technological advancement which has the potential to significantly ease the burden of those living with T1D. The AP functions as a device that mimics the glucose regulating functions of a healthy pancreas. It automatically works to control blood glucose levels and deliver insulin to prevent hyperglycemia and hypoglycemia. In addition, it also eases the burden of insulin, glucagon, or in some cases insulin and glucagon delivery by eliminating the need for injections.
The AP is a combination of 4 basic parts:
Wow! A lot going on! 🙂
The Artificial Pancreas is an important and substantial technological advancement which has the potential to significantly ease the burden of those living with T1D. The AP functions as a device that mimics the glucose regulating functions of a healthy pancreas. It automatically works to control blood glucose levels and deliver insulin to prevent hyperglycemia and hypoglycemia. In addition, it also eases the burden of insulin, glucagon, or in some cases insulin and glucagon delivery by eliminating the need for injections.
The AP is a combination of 4 basic parts:
- Algorithm: Software within the controller that determines appropriate dosing, based on information from the CGM and insulin pump.
- Controller: (smartphone, hand device, embedded in the pump) Houses the algorithm and provides glucose readings and other user information data.
- CGM: Measures glucose levels and sends information to the controller.
- Insulin Pump: Regulated by the algorithm, adjusts the amount of insulin delivery.
Wow! A lot going on! 🙂
